<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 9.4: Diabetes Management in the Elderly (Geriatric Care)</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE theme for Clinical/Geriatric */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Welcome/Intro Box */
        .welcome-box {
            background: linear-gradient(135deg, #eff6ff 0%, #dbeafe 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #bfdbfe;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #1e3a8a;
            font-weight: 600;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box .alert-label {
            font-weight: 600;
            margin: 0 0 12px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .alert-box.warning {
            background: #fff8e6;
            border-left-color: #ff9800;
        }

        .alert-box.warning .alert-label {
            color: #e65100;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Comparison Tables */
        .data-table-container {
            margin: 30px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        .data-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        .data-table th {
            background: #f3f4f6;
            padding: 15px;
            color: #1e3a8a;
            font-weight: 700;
            border-bottom: 2px solid #e5e7eb;
        }

        .data-table td {
            padding: 15px;
            border-bottom: 1px solid #f3f4f6;
            vertical-align: top;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .check-understanding .box-label {
            font-weight: 600;
            color: #8B6914;
            margin: 0 0 8px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .question-number {
            position: absolute;
            top: -12px;
            left: 20px;
            background: #1e3a8a;
            color: white;
            width: 28px;
            height: 28px;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-weight: 600;
            font-size: 13px;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            transition: background 0.2s ease;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #1e3a8a;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #eff6ff;
            border-radius: 8px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f3f4f6;
            padding: 25px;
            margin-top: 35px;
            border-radius: 12px;
            border: 1px solid #d1d5db;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #fafafa;
            border-radius: 12px;
            font-size: 14px;
            color: #666;
            border: 1px solid #eee;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            color: #333;
            font-size: 16px;
        }

        .references-box ul {
            padding-left: 20px;
            margin: 0;
        }

        .references-box li {
            margin-bottom: 8px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.9;
        }

        @media (max-width: 768px) {
            .lesson-container { padding: 20px 16px; }
            .toc-list { grid-template-columns: 1fr; }
            .stats-grid { grid-template-columns: repeat(2, 1fr); }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 9: Specialized Populations & Conditions</p>
            <h1 class="lesson-title">Lesson 9.4: Diabetes Management in the Elderly (Geriatric Care)</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 4 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Geriatric Shift</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Hypoglycemia: The Primary Threat</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Personalized Glycemic Targets</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Sarcopenia & The STABLE Method</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Cognitive Decline & "Type 3" Diabetes</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Nutritional Considerations for Aging</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Differentiate glycemic targets for healthy vs. frail older adults.</li>
                <li>Identify the physiological changes of aging that impact insulin sensitivity and glucose metabolism.</li>
                <li>Implement the STABLE Methodâ„¢ specifically for geriatric populations to prevent hypoglycemia.</li>
                <li>Recognize the bidirectional relationship between diabetes and cognitive impairment/dementia.</li>
                <li>Design nutritional and movement interventions that address sarcopenia and metabolic health simultaneously.</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>Specialized Care for the Golden Years</h3>
            <p>Managing diabetes in patients over the age of 65 requires a fundamental paradigm shift. While younger patients focus on preventing long-term microvascular complications over decades, geriatric care prioritizes <span class="highlight">safety, quality of life, and the avoidance of acute crises</span>. As a coach, you must navigate the complexities of polypharmacy, cognitive decline, and physical frailty, ensuring that the "cure" is not more burdensome than the condition itself.</p>
        </div>

        <div class="key-terms-box">
            <p class="box-label">ðŸ”¬ Key Terms to Know</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Sarcopenia</p>
                    <p class="definition">The age-related loss of skeletal muscle mass and strength, which significantly reduces the body's primary site for glucose disposal.</p>
                </div>
                <div class="term-item">
                    <p class="term">Polypharmacy</p>
                    <p class="definition">The concurrent use of multiple medications (usually 5+), increasing the risk of drug-drug interactions and adverse metabolic effects.</p>
                </div>
                <div class="term-item">
                    <p class="term">Hypoglycemia Unawareness</p>
                    <p class="definition">A condition common in the elderly where the typical warning signs of low blood sugar (tremors, sweating) are absent or blunted.</p>
                </div>
                <div class="term-item">
                    <p class="term">De-prescribing</p>
                    <p class="definition">The planned process of reducing or stopping medications that may no longer be beneficial or may be causing harm.</p>
                </div>
            </div>
        </div>

        <h2 id="section1">The Geriatric Shift: Why Standards Change</h2>
        <p>In geriatric diabetes care, the "one-size-fits-all" approach of aiming for an HbA1c below 7.0% can be dangerous. A 2022 meta-analysis involving over 1.2 million older adults found that <span class="highlight">mortality followed a U-shaped curve</span>, where both very high (A1c > 9%) and very low (A1c < 6.5%) levels increased the risk of death. This is largely due to the increased vulnerability of the aging brain and heart to glucose fluctuations.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">25%</div>
                    <div class="stat-label">Prevalence in 65+</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">2.1x</div>
                    <div class="stat-label">Fall Risk with Lows</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">40%</div>
                    <div class="stat-label">Have Sarcopenia</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">3x</div>
                    <div class="stat-label">Dementia Risk</div>
                </div>
            </div>
        </div>

        <p>Physiological aging alters the STABLE Methodâ„¢ framework. <span class="highlight">Renal function (eGFR)</span> naturally declines, meaning medications like Metformin or Sulfonylureas clear the body more slowly, extending their duration of action and increasing toxicity risks. Furthermore, the counter-regulatory hormone response (glucagon and epinephrine) to hypoglycemia is often delayed or diminished in older adults.</p>

        <h2 id="section2">Hypoglycemia: The Primary Threat</h2>
        <p>For the elderly, hypoglycemia is more than a temporary discomfort; it is a major cause of <span class="highlight">emergency room visits, hip fractures, and accelerated cognitive decline</span>. Severe hypoglycemia (requiring assistance) is associated with a 2-fold increase in the risk of developing dementia within five years.</p>

        <div class="alert-box warning">
            <p class="alert-label">Critical Safety Note</p>
            <p>In geriatric clients, hypoglycemia symptoms are often non-specific. Instead of sweating or shaking, they may present with <strong>confusion, dizziness, slurred speech, or sudden fatigue</strong>, which can be easily mistaken for dementia or a "mini-stroke" (TIA).</p>
        </div>

        <h2 id="section3">Personalized Glycemic Targets</h2>
        <p>The American Diabetes Association (ADA) and the Endocrine Society suggest categorizing older adults into three groups to determine safe targets. This aligns with our <strong>Stabilization (S)</strong> principle of the STABLE Methodâ„¢, where we prioritize minimizing variability over absolute low numbers.</p>

        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Patient Category</th>
                        <th>HbA1c Target</th>
                        <th>Fasting Glucose</th>
                        <th>Bedtime Glucose</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Healthy</strong> (Long life expectancy, few comorbidities)</td>
                        <td>&lt; 7.0% â€“ 7.5%</td>
                        <td>90â€“130 mg/dL</td>
                        <td>90â€“150 mg/dL</td>
                    </tr>
                    <tr>
                        <td><strong>Complex/Intermediate</strong> (Multiple chronic illnesses, 2+ ADL impairments)</td>
                        <td>&lt; 8.0%</td>
                        <td>90â€“150 mg/dL</td>
                        <td>100â€“180 mg/dL</td>
                    </tr>
                    <tr>
                        <td><strong>Very Complex/Poor Health</strong> (LTC resident, end-stage illness, dementia)</td>
                        <td>&lt; 8.5%</td>
                        <td>100â€“180 mg/dL</td>
                        <td>110â€“200 mg/dL</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: Arthur's Adjustment</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size: 13px;">Addressing Nocturnal Hypoglycemia in a 79-Year-Old</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">A</div>
                    <div class="patient-info">
                        <h4>Arthur, 79</h4>
                        <p>Type 2 Diabetes (22 years), Mild Cognitive Impairment, Hypertension</p>
                    </div>
                </div>
                <p><strong>Presentation:</strong> Arthur's daughter reported he was increasingly "confused and combative" in the mornings. His A1c was 6.4%, which his previous doctor praised. However, <strong>Tactical Tracking (T)</strong> via a 14-day CGM revealed Arthur was spending 18% of the night below 60 mg/dL.</p>
                <p><strong>Intervention:</strong> We applied <strong>Lifestyle Modulation (L)</strong> and <strong>Evolutionary Nutrition (E)</strong>. We relaxed his A1c target to 7.8%, reduced his evening insulin dose, and introduced a high-protein/fiber snack (Evolutionary-based) before bed to stabilize nighttime levels.</p>
                <p><strong>Outcome:</strong> Morning confusion vanished. His A1c rose to 7.6%, but his "Time in Range" (TIR) improved from 62% to 88% by eliminating the "rollercoaster" lows and subsequent rebound highs.</p>
            </div>
        </div>

        <h2 id="section4">Sarcopenia & The STABLE Method</h2>
        <p>The <strong>Active Sensitization (A)</strong> pillar of the STABLE Methodâ„¢ is critical for the elderly. Skeletal muscle is responsible for roughly 80% of postprandial glucose uptake. In sarcopenia, the "sink" for glucose is physically smaller, leading to higher spikes even with low carbohydrate intake.</p>
        
        <p>Interventions must focus on <span class="highlight">resistance training</span> (even seated or using bands) to maintain muscle mass and enhance GLUT4 translocation. Without muscle, insulin sensitivity remains low regardless of pharmaceutical intervention.</p>

        <h2 id="section5">Cognitive Decline & "Type 3" Diabetes</h2>
        <p>There is a robust, bidirectional link between hyperglycemia and neurodegeneration. Research published in <em>The Lancet</em> suggests that diabetes increases the risk of Alzheimerâ€™s disease by 60%. This has led researchers to label Alzheimerâ€™s as "Type 3 Diabetes," characterized by <span class="highlight">brain insulin resistance</span>.</p>
        
        <p>From a <strong>Biological Synergy (B)</strong> perspective, chronic hyperinsulinemia leads to the accumulation of amyloid-beta plaques because the enzyme responsible for breaking down insulin (Insulin-Degrading Enzyme) is also responsible for clearing these plaques. If it is busy with high insulin levels, the plaques accumulate.</p>

        <h2 id="section6">Nutritional Considerations for Aging</h2>
        <p>Applying <strong>Evolutionary-Based Nutrition (E)</strong> in geriatrics requires balancing metabolic health with nutrient density and ease of consumption. Older adults often face "Anorexia of Aging" or dental issues that make high-fiber, whole foods difficult to eat.</p>

        <ul class="content-list">
            <li><strong>Protein Prioritization:</strong> 1.2â€“1.5g of protein per kg of body weight is often necessary to combat sarcopenia, significantly higher than the standard RDA.</li>
            <li><strong>The "Food Order" Effect:</strong> Eating protein and vegetables before carbohydrates can reduce postprandial glucose spikes by up to 40% in older adults, even if the total carb count remains the same.</li>
            <li><strong>Hydration & Electrolytes:</strong> The thirst mechanism blunts with age. Dehydration can cause "pseudo-hyperglycemia" as blood volume decreases, concentrating the glucose.</li>
        </ul>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Why is an HbA1c of 6.5% potentially dangerous for an 82-year-old with moderate dementia?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">Tight control (A1c 6.5%) in frail elderly significantly increases the risk of severe hypoglycemia. In patients with dementia, they may not be able to recognize or communicate symptoms of a "low," leading to falls, seizures, or cardiovascular events. Guidelines suggest a more relaxed target of 8.0-8.5% for this population.</p>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">How does sarcopenia interfere with the 'Active Sensitization' (A) principle of the STABLE Method?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">Sarcopenia reduces the total volume of skeletal muscle available for glucose disposal. Since muscle is the primary site for clearing glucose from the blood, losing muscle mass makes the body more reliant on higher insulin levels, exacerbating insulin resistance and making blood sugar more difficult to stabilize.</p>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Safety First:</strong> Hypoglycemia prevention is the #1 priority in geriatric diabetes coaching.</li>
                <li><strong>Personalized Targets:</strong> Use the three-tier ADA health status categories to set HbA1c and glucose goals.</li>
                <li><strong>Muscle is Medicine:</strong> Active Sensitization through resistance training is vital to combat sarcopenia-induced insulin resistance.</li>
                <li><strong>Cognitive Connection:</strong> Monitor for "Type 3 Diabetes" signs; cognitive health and metabolic health are inextricably linked.</li>
                <li><strong>Tactical Tracking:</strong> CGMs are highly valuable for the elderly and their caregivers to detect silent nighttime hypoglycemia.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>American Diabetes Association (2023). "Older Adults: Standards of Care in Diabetesâ€”2023." <i>Diabetes Care</i>.</li>
                <li>Sinclair, A. et al. (2022). "Diabetes in older people: new insights and remaining challenges." <i>The Lancet Diabetes & Endocrinology</i>.</li>
                <li>Munshi, M. N. et al. (2019). "Management of Diabetes in Older Adults: An Endocrine Society Clinical Practice Guideline." <i>Journal of Clinical Endocrinology & Metabolism</i>.</li>
                <li>Luchsinger, J. A. (2020). "Diabetes and cognitive impairment: Shared mechanisms and clinical implications." <i>JAMA</i>.</li>
                <li>Cruz-Jentoft, A. J. et al. (2019). "Sarcopenia: revised European consensus on definition and diagnosis." <i>Age and Ageing</i>.</li>
                <li>Abdelhafiz, A. H. et al. (2015). "Hypoglycaemia, frailty and dementia in older people with type 2 diabetes: a close link." <i>Postgraduate Medical Journal</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy | Diabetes & Blood Sugar Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>